The U.S. Antifungal Drugs Market is evolving rapidly as advancements in fungal infection treatment address the growing burden of both superficial and invasive fungal diseases. Valued at USD 5.98 billion in 2024 and projected to reach USD 7.96 billion by 2034 at a CAGR of 2.9%, the market reflects sustained demand for effective therapeutic solutions. Fungal infection treatment has become...